Company Overview

PRELUDE THERAPEUTICS INC

PRLD
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
12M
2025 FY
Net Income
-99M
2025 FY
Shares Outstanding
77M
2025 FY
EPS
-1.29USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1678660
Exchange
Nasdaq
Location
US